IL291727A - Method and compositions for treating coronavirus infection - Google Patents
Method and compositions for treating coronavirus infectionInfo
- Publication number
- IL291727A IL291727A IL291727A IL29172722A IL291727A IL 291727 A IL291727 A IL 291727A IL 291727 A IL291727 A IL 291727A IL 29172722 A IL29172722 A IL 29172722A IL 291727 A IL291727 A IL 291727A
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- coronavirus infection
- treating coronavirus
- treating
- infection
- Prior art date
Links
- 208000001528 Coronaviridae Infections Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063002735P | 2020-03-31 | 2020-03-31 | |
| US202063010246P | 2020-04-15 | 2020-04-15 | |
| US202063014294P | 2020-04-23 | 2020-04-23 | |
| US202063017263P | 2020-04-29 | 2020-04-29 | |
| US202063021512P | 2020-05-07 | 2020-05-07 | |
| US202063029530P | 2020-05-24 | 2020-05-24 | |
| US202063034800P | 2020-06-04 | 2020-06-04 | |
| US16/895,920 US10729735B1 (en) | 2016-09-14 | 2020-06-08 | Method and compostitions for treating coronavirus infection |
| US202063042656P | 2020-06-23 | 2020-06-23 | |
| US202063051576P | 2020-07-14 | 2020-07-14 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL291727A true IL291727A (en) | 2022-05-01 |
| IL291727B1 IL291727B1 (en) | 2023-03-01 |
| IL291727B2 IL291727B2 (en) | 2023-07-01 |
Family
ID=77930101
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL277315A IL277315B (en) | 2020-03-31 | 2020-09-13 | Methods and composition for treating coronavirus infection |
| IL291727A IL291727B2 (en) | 2020-03-31 | 2022-03-27 | Method and compositions for treating coronavirus infection |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL277315A IL277315B (en) | 2020-03-31 | 2020-09-13 | Methods and composition for treating coronavirus infection |
Country Status (8)
| Country | Link |
|---|---|
| JP (2) | JP7153083B2 (en) |
| KR (2) | KR20220151038A (en) |
| IL (2) | IL277315B (en) |
| MX (2) | MX2020009095A (en) |
| RU (1) | RU2020130238A (en) |
| SG (1) | SG11202105728YA (en) |
| TW (2) | TWI790048B (en) |
| WO (1) | WO2021201903A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11351149B2 (en) * | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
| WO2023022866A1 (en) * | 2021-08-16 | 2023-02-23 | Phoenix Biotechnology, Inc. | Method and compositions for treating animal viral infections |
| WO2023212353A1 (en) * | 2022-04-29 | 2023-11-02 | Emory University | Viral entry inhibitors derived from botanicals |
| CN115364136A (en) * | 2022-09-05 | 2022-11-22 | 深圳市药品检验研究院（深圳市医疗器械检测中心） | Application of Crassulaceae plant extract in preparing medicine for resisting novel coronavirus and influenza virus infection |
Family Cites Families (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1394196A (en) | 1971-10-03 | 1975-05-14 | Hisamitsu Pharmaceutical Co | Process for isolating oleandrin from nerium odorum |
| PT84857B (en) | 1986-05-13 | 1990-02-08 | Huseyin Ziya Ozel | PROCESS FOR THE PREPARATION OF EXTRACTS OF NERIUM SPECIES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM |
| JPS6333341A (en) * | 1986-07-28 | 1988-02-13 | Seitetsu Kagaku Co Ltd | Treatment of glycoside |
| US5236132A (en) | 1992-01-03 | 1993-08-17 | Vortec, Inc. | Gradient-force comminuter/dehydrator apparatus and method |
| US5598979A (en) | 1995-04-20 | 1997-02-04 | Vortec, Inc. | Closed loop gradient force comminuting and dehydrating system |
| CA2191923C (en) | 1996-12-03 | 2000-10-24 | Ji-Won Yoon | Portulaca oleracea and tumor cell growth |
| DK1079824T3 (en) | 1998-05-19 | 2011-11-21 | Res Dev Foundation | Triterpene compositions and methods for their use |
| JP2002526452A (en) | 1998-09-24 | 2002-08-20 | オゼル・ファーマスーティカルズ・インコーポレイテッド | Oleander extract, its pharmaceutical composition and its preparation method |
| US6517015B2 (en) | 2000-03-21 | 2003-02-11 | Frank F. Rowley, Jr. | Two-stage comminuting and dehydrating system and method |
| NZ524087A (en) | 2000-08-18 | 2004-08-27 | Univ Illinois | Prodrugs of betulinic acid derivatives for the treatment of cancer and HIV |
| US6715705B2 (en) | 2001-03-16 | 2004-04-06 | Frank F. Rowley, Jr. | Two-stage comminuting and dehydrating system and method |
| ATE295087T1 (en) | 2001-04-09 | 2005-05-15 | Loders Croklaan Bv | CONCENTRATE OF TRITERPENES |
| CA2446748C (en) | 2001-05-11 | 2011-03-08 | University Of Ottawa | Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods |
| EP1397149A1 (en) | 2001-06-18 | 2004-03-17 | S.A.V Virex Co Ltd | Nerium oleander extract, compositions containing the nerium oleander l. extract and a method of preparation of this extract |
| US20040082521A1 (en) | 2002-03-29 | 2004-04-29 | Azaya Therapeutics Inc. | Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases |
| US7179484B2 (en) | 2002-11-06 | 2007-02-20 | Azaya Therapeutics, Inc. | Protein-stabilized liposomal formulations of pharmaceutical agents |
| US20050026849A1 (en) | 2003-03-28 | 2005-02-03 | Singh Chandra U. | Water soluble formulations of digitalis glycosides for treating cell-proliferative and other diseases |
| WO2005090380A1 (en) | 2004-03-17 | 2005-09-29 | Panacos Pharmaceuticals, Inc. | Pharmaceuticals salts of 3-o-(3',3'-dimethylsuccinyl) betulinic acid |
| US7118508B2 (en) | 2004-07-28 | 2006-10-10 | General Motors Corporation | Planetary transmissions having three interconnected gear members and clutched input members |
| ES2618423T3 (en) | 2004-08-13 | 2017-06-21 | Biolase, Inc | Laser handheld instrument structure, and methods |
| CA2597300C (en) | 2005-02-09 | 2012-11-27 | Rama Mukherjee | Novel betulinic acid derivatives |
| WO2006105354A1 (en) | 2005-03-29 | 2006-10-05 | Regents Of The University Of Minnesota | Selective oxidation of triterpenes employing tempo |
| US20060252733A1 (en) | 2005-04-07 | 2006-11-09 | Novelix Pharmaceuticals, Inc. | Betulin, betulin derivatives, betulinic acid and betulinic acid derivatives as novel therapeutics in the treatment of disease of lipid and/or glucose metabolism |
| US20090131714A1 (en) | 2005-06-08 | 2009-05-21 | Krasutsky Pavel A | Synthesis of betulonic and betulinic aldehydes |
| CA2611435C (en) | 2005-06-10 | 2013-01-08 | Pola Chemical Industries Inc. | Novel triterpenic acid derivative and preparation for external application for skin comprising the same |
| US7402325B2 (en) | 2005-07-28 | 2008-07-22 | Phoenix Biotechnology, Inc. | Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander |
| ZA200805703B (en) | 2005-12-16 | 2009-10-28 | Panacos Pharmaceuticals Inc | Preparation of pharmaceutical salts of 3-0-(3',3'-dimethyl-succinyl) betulinic acid |
| EP1803461A1 (en) | 2005-12-27 | 2007-07-04 | Heinz-Herbert Fiebig | Therapeutic use of an extract from the leaves of Nerium oleander |
| GB0604535D0 (en) | 2006-03-07 | 2006-04-12 | Sndv Sprl | Betulonic acid derivatives |
| WO2008063318A2 (en) | 2006-10-12 | 2008-05-29 | The Texas A & M University System And Safe Et Al | Betulinic acid, derivatives and analogs thereof and uses therefor |
| WO2008057420A2 (en) | 2006-11-03 | 2008-05-15 | Panacos Pharmaceuticals, Inc. | Extended triterpene derivatives |
| WO2008091532A1 (en) | 2007-01-19 | 2008-07-31 | Panacos Pharmaceuticals, Inc. | Salts of 3-o-(3',3'-dimethylsuccinyl)betulinic acid and solid state forms thereof |
| US8987212B2 (en) | 2007-08-07 | 2015-03-24 | Muhammed Majeed | Oleanoyl peptide composition and method of treating skin aging |
| MX2010005081A (en) | 2007-11-13 | 2010-06-23 | Phoenix Biotechnology Inc | Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside. |
| SI2276493T1 (en) | 2008-04-18 | 2019-04-30 | Reata Pharmaceuticals, Inc. | Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17 |
| US8071632B2 (en) | 2008-04-18 | 2011-12-06 | Reata Pharmaceuticals, Inc. | Antioxidant inflammation modulators: novel derivatives of oleanolic acid |
| TWI442925B (en) | 2008-04-18 | 2014-07-01 | Reata Pharmaceuticals Inc | Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring |
| BRPI0911422B8 (en) | 2008-04-18 | 2021-05-25 | Reata Pharmaceuticals Inc | inflammatory antioxidant modulating compounds, pharmaceutical composition and their uses |
| EP2340257A4 (en) | 2008-09-10 | 2012-09-26 | Univ Quebec A Chicoutimi | Bidesmosidic betulin and betulinic acid derivatives and uses thereof as antitumor agents |
| CN102186487B (en) | 2008-10-14 | 2013-05-15 | 奈瑞姆生物技术公司 | Process for extracting cardiac glycodides and compositions |
| US8778990B2 (en) | 2008-11-04 | 2014-07-15 | Trustees Of Dartmouth College | Betulinic acid derivatives and methods of use thereof |
| US20110038852A1 (en) * | 2009-06-10 | 2011-02-17 | 3-V Biosciences, Inc. | Antivirals that target transporters, carriers, and ion channels |
| US8802727B2 (en) | 2009-07-14 | 2014-08-12 | Hetero Research Foundation, Hetero Drugs Limited | Pharmaceutically acceptable salts of betulinic acid derivatives |
| CN101704872B (en) | 2009-11-23 | 2012-06-27 | 张南 | 23-hydroxybetulinic acid derivatives as well as preparation methods and application thereof |
| US8685469B2 (en) | 2009-11-30 | 2014-04-01 | University Of Kwazulu-Natal | In vitro anti-sickling activity of betulinic acid, oleanolic acid and their derivatives |
| KR101811462B1 (en) | 2010-01-11 | 2018-01-25 | 피닉스 바이오테크놀러지 인코포레이티드. | Composition treating neurological conditions comprising nerium oleander |
| US10383886B2 (en) | 2010-01-11 | 2019-08-20 | Phoenix Biotechnology, Inc. | Method of treating neurological conditions with oleandrin |
| US9011937B2 (en) | 2010-11-22 | 2015-04-21 | Phoenix Biotechnology, Inc. | Method of treating neurological conditions with extract of Nerium species or Thevetia species |
| TWI386415B (en) | 2010-02-02 | 2013-02-21 | Univ Kaohsiung Medical | Ursolic acid derivative and pharmaceutical composition thereof |
| TWI410431B (en) | 2010-12-22 | 2013-10-01 | Ind Tech Res Inst | Use of oleanolic acid derivatives in the manufacture of a medicament to prevent or treat hepatitis c |
| US20140221328A1 (en) | 2011-01-10 | 2014-08-07 | Bandi Parthasaradhi Reddy | Pharmaceutically acceptable salts of novel betulinic acid derivatives |
| ES2552512T3 (en) | 2011-01-31 | 2015-11-30 | Bristol-Myers Squibb Company | C-28 amines of C-3 modified betulinic acid derivatives as inhibitors of human immunodeficiency virus maturation |
| CN102558280B (en) | 2011-11-18 | 2014-09-17 | 温州大学 | Method for producing 30-halogenated betulinic acid |
| WO2013079024A1 (en) | 2011-12-01 | 2013-06-06 | 杭州本生药业有限公司 | Oleanolic acid amidate derivatives, preparation methods and uses thereof |
| NO2786757T3 (en) | 2011-12-01 | 2018-01-13 | ||
| US20150119373A1 (en) | 2012-04-24 | 2015-04-30 | Hetero Research Foundation | Novel betulinic acid derivatives as hiv inhibitors |
| US8921419B2 (en) | 2012-05-08 | 2014-12-30 | Trustees Of Dartmouth College | Triterpenoids and compositions containing the same |
| CN104684883A (en) | 2012-08-14 | 2015-06-03 | 内克索利戈有限公司 | Novel ursolic acid derivative and method for preparing same |
| NZ705213A (en) | 2012-09-10 | 2018-07-27 | Reata Pharmaceuticals Inc | C17-heteroaryl derivatives of oleanolic acid and methods of use thereof |
| WO2014040073A1 (en) | 2012-09-10 | 2014-03-13 | Reata Pharmaceuticals, Inc. | C13-hydroxy derivatives of oleanolic acid and methods of use thereof |
| ES2731758T3 (en) | 2012-09-10 | 2019-11-18 | Reata Pharmaceuticals Inc | C17 alkanediyl and alkenodiyl derivatives of oleanolic acid and methods of use thereof |
| US9637516B2 (en) | 2012-12-31 | 2017-05-02 | Hetero Research Foundation | Betulinic acid proline derivatives as HIV inhibitors |
| EA027861B1 (en) | 2013-02-25 | 2017-09-29 | Бристол-Майерс Сквибб Компани | C-3 alkyl and alkenyl modified betulinic acid derivatives or pharmaceutical salts thereof, antiviral pharmaceutical composition and pharmaceutical composition for the treatment of hiv based thereon |
| WO2015195776A1 (en) | 2014-06-19 | 2015-12-23 | Bristol-Myers Squibb Company | Betulinic acid derivatives with hiv maturation inhibitory activity |
| US20190216835A1 (en) * | 2016-06-09 | 2019-07-18 | University Of Massachusetts | Inhibition of Zika Virus Infection |
| ES2874187T3 (en) | 2016-09-14 | 2021-11-04 | Phoenix Biotechnology Inc | Method and compositions for the treatment of a viral infection |
| US10596186B2 (en) | 2016-09-14 | 2020-03-24 | Phoenix Biotechnology, Inc. | Method and compositions for treating viral infections |
| WO2019055119A1 (en) | 2017-09-14 | 2019-03-21 | Phoenix Biotechnology, Inc. | Method and composition for treating viral infection |
| US10702567B2 (en) * | 2016-09-14 | 2020-07-07 | Phoenix Biotechnology, Inc. | Method and compositions for treating viral infection |
-
2020
- 2020-07-14 KR KR1020227038215A patent/KR20220151038A/en active IP Right Grant
- 2020-07-14 MX MX2020009095A patent/MX2020009095A/en unknown
- 2020-07-14 JP JP2020554292A patent/JP7153083B2/en active Active
- 2020-07-14 SG SG11202105728YA patent/SG11202105728YA/en unknown
- 2020-07-14 KR KR1020207026847A patent/KR102464428B1/en active IP Right Grant
- 2020-07-14 RU RU2020130238A patent/RU2020130238A/en unknown
- 2020-07-14 WO PCT/US2020/042009 patent/WO2021201903A1/en unknown
- 2020-08-31 MX MX2022009176A patent/MX2022009176A/en unknown
- 2020-09-13 IL IL277315A patent/IL277315B/en unknown
-
2021
- 2021-01-15 TW TW110147017A patent/TWI790048B/en active
- 2021-01-15 TW TW110101732A patent/TWI753747B/en active
-
2022
- 2022-03-27 IL IL291727A patent/IL291727B2/en unknown
- 2022-09-30 JP JP2022157628A patent/JP2022186737A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022186737A (en) | 2022-12-15 |
| WO2021201903A1 (en) | 2021-10-07 |
| RU2020130238A (en) | 2022-03-14 |
| IL291727B2 (en) | 2023-07-01 |
| JP7153083B2 (en) | 2022-10-13 |
| TWI753747B (en) | 2022-01-21 |
| TW202137991A (en) | 2021-10-16 |
| SG11202105728YA (en) | 2021-11-29 |
| KR20210124010A (en) | 2021-10-14 |
| TWI790048B (en) | 2023-01-11 |
| TW202211926A (en) | 2022-04-01 |
| MX2022009176A (en) | 2022-08-17 |
| KR20220151038A (en) | 2022-11-11 |
| IL277315B (en) | 2022-05-01 |
| MX2020009095A (en) | 2022-07-28 |
| JP2022522074A (en) | 2022-04-14 |
| IL291727B1 (en) | 2023-03-01 |
| IL277315A (en) | 2021-09-30 |
| RU2020130238A3 (en) | 2022-03-14 |
| KR102464428B1 (en) | 2022-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL291727B1 (en) | Method and compositions for treating coronavirus infection | |
| EP4100019A4 (en) | Method for treating coronavirus infections | |
| EP4093758A4 (en) | Methods and compositions for treating and preventing viral infection | |
| EP4096675A4 (en) | Compositions and methods for treating long covid | |
| EP4103164A4 (en) | Compounds for treating coronavirus infection | |
| IL299295A (en) | Methods and compositions for treating hemophilia | |
| ZA202206163B (en) | Methods of treating coronavirus | |
| GB202011871D0 (en) | Composition and method | |
| IL307872A (en) | Novel compositions and methods for treating coronavirus infections | |
| EP4114176A4 (en) | Sterilization compositions and methods for using thereof | |
| EP4103192A4 (en) | Compositions and methods for treating coronavirus infections | |
| EP4009981C0 (en) | Method and compositions for treating coronavirus infection | |
| EP4120863A4 (en) | Method for treatment of coronavirus infection | |
| EP4138862A4 (en) | Compositions and methods for treating upper respiratory infections | |
| EP4114438A4 (en) | Methods and compositions for treating muscle atrophy | |
| EP4132503A4 (en) | Methods for treatment of coronavirus infections | |
| ZA202110332B (en) | Composition for treating coronavirus infection | |
| IL277546A (en) | Methods and compositions for treating coronaviral infections | |
| GB202215010D0 (en) | Compositions for preventing and treating infection | |
| GB202205515D0 (en) | Compositions for preventing and treating infection | |
| AU2021901169A0 (en) | Novel compositions and methods for treating coronavirus infections | |
| GB202005986D0 (en) | Methods and compositions for treating and combatting tuberulosis | |
| AU2022900358A0 (en) | Novel compositions and methods for treating coronavirus infections | |
| GB202008288D0 (en) | Methods and compositions for treating and combatting sars-cov and sars-cov-2 | |
| GB202005987D0 (en) | Methods and compositions for treating and combatting sars-cov and sars-cov-2 |